Special Chemistry
Dylan Dodd, MD, PhD
Assistant Professor of Pathology and of Microbiology & Immunology
Dylan Dodd completed his M.D. and Ph.D. degrees at the University of Illinois in Urbana-Champaign. His thesis research was in Professor Isaac Cann’s laboratory in the Department of Microbiology, and focused on the molecular mechanisms for energy capture by gastrointestinal bacteria. Dylan then moved to Stanford where he completed residency training in Clinical Pathology. He continued at Stanford as an Instructor in Justin Sonnenburg’s laboratory, where he studied how gastrointestinal bacteria contribute to a large pool of bioactive small molecules that impact host physiology.
Matthew M. Hernandez, MD, PhD
Assistant Professor of Pathology (Clinical Microbiology)
Associate Director, Clinical Microbiology Laboratory
Associate Director, Clinical Virology Laboratory
Matt Hernandez received his MD/PhD from the Icahn School of Medicine at Mount Sinai (ISMMS) in New York City. His graduate work focused on viral-host interactions and tracing HIV evolution in vivo using genomic tools. During his training, he applied his skills to the clinical laboratory and helped found the ISMMS Personalized Virology Initiative. Through this, he developed genomic surveillance programs to capture spread, and evolution of respiratory viruses and established innovative testing to meet SARS-CoV-2 diagnostic needs for New Yorkers early in the COVID-19 pandemic. After medical school, he completed residency training in Clinical Pathology at ISMMS. During this, he continued to foster his passions for pathogen evolution and used diagnostics to characterize real-time introductions and spread of SARS-CoV-2 in New York and South America as well as helped bring on Mpox diagnostic assays to tackle the global outbreak. After residency, he completed his medical microbiology fellowship at Beth Israel Deaconess Medical Center in Boston, MA. He then moved west to join the Department of Pathology at Stanford where he serves as the Associate Director of the Clinical Microbiology and Virology Laboratories. His research interests include exploiting genomics to (1) dissect inter- and intra-host pathogen diversity, (2) to shed light on mechanisms shaping pathogen evolution and drug-resistance development, and (3) to develop novel, optimized diagnostics to capture emergent pathogens. He also loves teaching and strives to open the door to others interested in infectious disease diagnostics and research.
Ruben Yiqi Luo, PhD
Assistant Professor of Pathology
Associate Director, Clinical Chemistry & Immunology Laboratory
Ruben Y. Luo, PhD, DABCC, FADLM is an Assistant Professor of Pathology at Stanford University and Associate Director of Clinical Chemistry Laboratory at Stanford Health Care. He has been dedicated to innovations in translational laboratory medicine: discovery of novel diagnostic markers and innovation of diagnostic technologies. His research focuses on (1) discovering the clinical diagnostic value of molecular characteristics of protein biomarkers, and (2) developing high-resolution mass spectrometry and label-free optical sensing technologies for characterization and accurate measurement of biomarkers. He completed his clinical chemistry fellowship at University of California San Francisco. Prior to the fellowship, he had several years of work experience in the clinical diagnostic industry. He received his PhD in analytical chemistry from Stanford University, and BS in chemistry from Peking University.
Run-Zhang Shi, MD, PhD
Clinical Associate Professor of Pathology (Clinical Chemistry & Immunology)
Co-Director, Clinical Chemistry & Immunology Laboratory
Dr. Run Zhang Shi is a Clinical Associate Professor of Pathology specializing in Clinical Chemistry and Immunology. His work within the Clinical Immunology lab include: Therapeutic drug monitoring; Steroid hormones; Tumor markers; Infecious disease serology; Trace and toxic elements; Clinical diagnostic protein electrophoresis; and Allergy tests. Dr. Shi's research includes: Clinical chemistry and therapeutic drug monitoring; adult and pediatric clinical endocrine testing; screening, detection and follow up of multiple myeloma; tumor markers; clinical utility of tandem mass spectrometry and high resolution mass spectrometry.